In the article, which recognized Mr. Trump as the TIME Person of the Year, he said, “I’m going to bring down drug prices.”
While he did not express how he plans to do so, Mr. Trump has previously said he was open to allowing the importation of cheaper medicines from overseas, reports Reuters. The drug industry and U.S. health regulators have consistently opposed this measure, according to the report.
The biotech index fell almost 4 percent on Wednesday to its lowest level since the election, reports Reuters. The NYSE Arca Pharmaceutical Index of U.S. and European drug companies dropped 2.2 percent, marking a three-year low.
More articles on supply chain:
Healthcare Supply Chain ranks Intermountain Healthcare #1 in nation
Corporate supply chains produce $906B in annual revenue linked to deforestation
Why this Supreme Court patent case may have expensive implications for device manufacturers
